Acute Myeloid Leukemia News and Research

RSS
Acute Myeloid Leukemia (AML) is a rapidly progressing cancer of the blood characterized by the uncontrolled proliferation of immature blast cells in the bone marrow. The Leukemia and Lymphoma Society estimates that over 13,000 new cases of AML were diagnosed and approximately 9,000 deaths from AML occurred in the U.S. during 2007. AML is generally a disease of older adults, and the median age of a patient diagnosed with AML is about 67 years. A majority of elderly patients are not considered candidates for standard induction therapy or decline therapy, resulting in an acute need for new treatment options.
HIV patient treated with blood stem cell transplant for leukemia achieves long-term remission

HIV patient treated with blood stem cell transplant for leukemia achieves long-term remission

New mutation may define a high-risk subtype of pediatric acute myeloid leukemia

New mutation may define a high-risk subtype of pediatric acute myeloid leukemia

New high-risk subtype of relapsed pediatric AML revealed

New high-risk subtype of relapsed pediatric AML revealed

A third known case of HIV remission involving stem cell transplant documented

A third known case of HIV remission involving stem cell transplant documented

Molecular cage helps researchers to get atomic-level details of key cancer protein

Molecular cage helps researchers to get atomic-level details of key cancer protein

New method decodes the role of DDX41 protein in preventing double-strand breaks in DNA

New method decodes the role of DDX41 protein in preventing double-strand breaks in DNA

Researchers compare survival rates of AML patients treated with two forms of transplantation methods

Researchers compare survival rates of AML patients treated with two forms of transplantation methods

Casting a wider net in zebrafish imaging

Casting a wider net in zebrafish imaging

Study finds new treatment option for patients with relapsed or refractory peripheral T-cell lymphoma

Study finds new treatment option for patients with relapsed or refractory peripheral T-cell lymphoma

Novel immunotherapy shows promise for children, young adults with recurrent AML

Novel immunotherapy shows promise for children, young adults with recurrent AML

Statistical models predict outcomes for patients receiving non-intensive AML therapy

Statistical models predict outcomes for patients receiving non-intensive AML therapy

Study uncovers important genetic predispositions for acute myeloid leukemia

Study uncovers important genetic predispositions for acute myeloid leukemia

Donor cells with clonal hematopoiesis may improve bone marrow transplant outcomes

Donor cells with clonal hematopoiesis may improve bone marrow transplant outcomes

Experts develop a functional precision medicine approach to assign therapies to cancer patients

Experts develop a functional precision medicine approach to assign therapies to cancer patients

New research finds disturbing lack of crucial blood cancer medication

New research finds disturbing lack of crucial blood cancer medication

NanoTCE technology shows promise for treatment of acute myeloid leukemia

NanoTCE technology shows promise for treatment of acute myeloid leukemia

Drug combination highly effective in children with standard- and high-risk acute promyelocytic leukemia

Drug combination highly effective in children with standard- and high-risk acute promyelocytic leukemia

Researchers identify safety concerns with neuroblastoma candidate drug

Researchers identify safety concerns with neuroblastoma candidate drug

Interferon treatment coupled with bone marrow transplant reduces risk of leukemia recurrence

Interferon treatment coupled with bone marrow transplant reduces risk of leukemia recurrence

Research may lead to breakthroughs in combating cancer drug resistances

Research may lead to breakthroughs in combating cancer drug resistances